Bank of America Reiterates Neutral Rating for Mettler-Toledo International (MTD)

Mettler-Toledo International (NYSE:MTD)‘s stock had its “neutral” rating reiterated by investment analysts at Bank of America in a report released on Tuesday, Briefing.com Automated Import reports. They currently have a $755.00 price target on the medical instruments supplier’s stock, up from their previous price target of $725.00. Bank of America‘s target price indicates a potential upside of 1.38% from the company’s current price.

A number of other research analysts have also weighed in on MTD. Evercore ISI lowered shares of Mettler-Toledo International from an “in-line” rating to an “underperform” rating in a research report on Thursday, January 3rd. ValuEngine downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Friday, January 4th. Finally, Zacks Investment Research downgraded shares of Mettler-Toledo International from a “hold” rating to a “sell” rating in a report on Tuesday, January 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $650.67.

Mettler-Toledo International stock traded up $0.36 on Tuesday, reaching $744.70. 568 shares of the stock were exchanged, compared to its average volume of 120,061. The firm has a market cap of $18.49 billion, a price-to-earnings ratio of 36.65, a P/E/G ratio of 2.63 and a beta of 1.35. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.42 and a quick ratio of 1.06. Mettler-Toledo International has a twelve month low of $500.74 and a twelve month high of $750.00.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, February 7th. The medical instruments supplier reported $6.85 earnings per share for the quarter, topping the Zacks’ consensus estimate of $6.74 by $0.11. The firm had revenue of $817.92 million during the quarter, compared to analyst estimates of $807.58 million. Mettler-Toledo International had a net margin of 17.46% and a return on equity of 94.57%. The business’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.97 EPS. As a group, sell-side analysts expect that Mettler-Toledo International will post 22.66 earnings per share for the current year.

In other news, insider Gerry Keller sold 250 shares of the business’s stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $664.50, for a total transaction of $166,125.00. Following the transaction, the insider now owns 404 shares in the company, valued at approximately $268,458. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Christian Magloth sold 1,500 shares of the business’s stock in a transaction dated Wednesday, February 13th. The stock was sold at an average price of $666.91, for a total transaction of $1,000,365.00. Following the transaction, the insider now owns 850 shares in the company, valued at approximately $566,873.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 150,995 shares of company stock worth $100,997,450. Insiders own 3.50% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of MTD. Lindbrook Capital LLC bought a new stake in Mettler-Toledo International during the fourth quarter worth about $27,000. Executive Wealth Management LLC bought a new stake in Mettler-Toledo International during the fourth quarter worth about $33,000. CWM LLC grew its stake in Mettler-Toledo International by 108.9% during the fourth quarter. CWM LLC now owns 94 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 49 shares during the last quarter. First Personal Financial Services grew its stake in Mettler-Toledo International by 38.2% during the fourth quarter. First Personal Financial Services now owns 94 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 26 shares during the last quarter. Finally, Van ECK Associates Corp grew its stake in Mettler-Toledo International by 36.6% during the fourth quarter. Van ECK Associates Corp now owns 97 shares of the medical instruments supplier’s stock worth $55,000 after buying an additional 26 shares during the last quarter. 95.69% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

Recommended Story: What is a Buy-Side Analyst?

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit